Arkolith/Insider Trading/SMMT/Form 4

Duggan Robert W

Co-Chief Executive Officer, Director, 10% OwnerSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Jun 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 30, 2025Option exercise(M)75K$2.64$197K555.8M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 30, 2025Option exercise(M)75K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599298-25-000106) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML